Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claire Leurent

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Primary Care Companion to the Journal of Clinical Psychiatry|June 29, 2010
Desvenlafaxine and weight change in major depressive disorderKaren A Tourian, Claire Leurent, Jay Graepel, et al.
The EMBO Journal|July 3, 2002
Mapping histone fold TAFs within yeast TFIIDClaire Leurent, Steven Sanders, Christine Ruhlmann, et al.
The EMBO Journal|February 7, 2004
Mapping key functional sites within yeast TFIIDClaire Leurent, Steven L Sanders, Màté A Demény, et al.
Journal of Alzheimer'S Disease : JAD|August 20, 2019
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects of PF-06751979, a Potent and Selective Oral BACE1 Inhibitor: Results from Phase I Studies in Healthy Adults and Healthy Older SubjectsRuolun Qiu, Jae Eun Ahn, Robert Alexander, et al.
Journal of Clinical Psychopharmacology|January 16, 2010
Desvenlafaxine for the prevention of relapse in major depressive disorder: results of a randomized trialKarl Rickels, Stuart A Montgomery, Karen A Tourian, et al.
Clinical Pharmacology and Therapeutics|July 18, 2019
Pharmacokinetic and Pharmacodynamic Effects of a γ-Secretase Modulator, PF-06648671, on CSF Amyloid-β Peptides in Randomized Phase I StudiesJae Eun Ahn, Charles Carrieri, Fernando Dela Cruz, et al.
Annals of Clinical and Translational Neurology|April 26, 2019
Immunotherapy with ponezumab for probable cerebral amyloid angiopathyClaire Leurent, James A Goodman, Yao Zhang, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Primary Care Companion to the Journal of Clinical Psychiatry|June 29, 2010
Desvenlafaxine and weight change in major depressive disorderKaren A Tourian, Claire Leurent, Jay Graepel, et al.
The EMBO Journal|July 3, 2002
Mapping histone fold TAFs within yeast TFIIDClaire Leurent, Steven Sanders, Christine Ruhlmann, et al.
The EMBO Journal|February 7, 2004
Mapping key functional sites within yeast TFIIDClaire Leurent, Steven L Sanders, Màté A Demény, et al.
Journal of Alzheimer'S Disease : JAD|August 20, 2019
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects of PF-06751979, a Potent and Selective Oral BACE1 Inhibitor: Results from Phase I Studies in Healthy Adults and Healthy Older SubjectsRuolun Qiu, Jae Eun Ahn, Robert Alexander, et al.
Journal of Clinical Psychopharmacology|January 16, 2010
Desvenlafaxine for the prevention of relapse in major depressive disorder: results of a randomized trialKarl Rickels, Stuart A Montgomery, Karen A Tourian, et al.
Clinical Pharmacology and Therapeutics|July 18, 2019
Pharmacokinetic and Pharmacodynamic Effects of a γ-Secretase Modulator, PF-06648671, on CSF Amyloid-β Peptides in Randomized Phase I StudiesJae Eun Ahn, Charles Carrieri, Fernando Dela Cruz, et al.
Annals of Clinical and Translational Neurology|April 26, 2019
Immunotherapy with ponezumab for probable cerebral amyloid angiopathyClaire Leurent, James A Goodman, Yao Zhang, et al.
Pageof 1